Identifying Predictors of Interferon-γ Release Assay Results in Pediatric Latent Tuberculosis: A Protective Role of Bacillus Calmette-Guérin?: A pTB-NET Collaborative Study
- 15 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 186 (4) , 378-384
Abstract
Rationale: Interferon-γ (IFN-γ) release assays are widely used to diagnose latent infection with Mycobacterium tuberculosis in adults, but their performance in children remains incompletely evaluated to date. Objectives: To investigate factors influencing results of IFN-γ release assays in children using a large European data set. Methods: The Pediatric Tuberculosis Network European Trials group pooled and analyzed data from five sites across Europe comprising 1,128 children who were all investigated for latent tuberculosis infection by tuberculin skin test and at least one IFN-γ release assay. Multivariate analyses examined age, bacillus Calmette-Guérin (BCG) vaccination status, and sex as predictor variables of results. Subgroup analyses included children who were household contacts. Measurements and Main Results: A total of 1,093 children had a QuantiFERON-TB Gold In-Tube assay and 382 had a T-SPOT.TB IFN-γ release assay. Age was positively correlated with a positive blood result (QuantiFERON-TB Gold In-Tube: odds ratio [OR], 1.08 per year increasing age [P < 0.0001]; T-SPOT.TB: OR, 1.14 per year increasing age [P < 0.001]). A positive QuantiFERON-TB Gold In-Tube result was shown by 5.5% of children with a tuberculin skin test result less than 5 mm, by 14.8% if less than 10 mm, and by 20.2% if less than 15 mm. Prior BCG vaccination was associated with a negative IFN-γ release assay result (QuantiFERON-TB Gold In-Tube: OR, 0.41 [P < 0.001]; T-SPOT.TB: OR, 0.41 [P < 0.001]). Young age was a predictor of indeterminate IFN-γ release assay results, but indeterminate rates were low (3.6% in children < 5 yr, 1% in children > 5 yr). Conclusions: Our data show that BCG vaccination may be effective in protecting children against Mycobacterium tuberculosis infection. To restrict use of IFN-γ release assays to children with positive skin tests risks underestimating latent infection.Keywords
This publication has 37 references indexed in Scilit:
- The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in ChildrenThe Pediatric Infectious Disease Journal, 2011
- Secondary Attack Rate of Tuberculosis in Urban Households in Kampala, UgandaPLOS ONE, 2011
- Pathogenesis, Immunology, and Diagnosis of LatentMycobacterium tuberculosisInfectionJournal of Immunology Research, 2010
- QuantiFERON®-TB Gold In-Tube as help for the diagnosis of tuberculosis in a French pediatric hospitalDiagnostic Microbiology and Infectious Disease, 2010
- Significance of reduced reactivity in ELISPOT assay to RD antigens ofMycobacterium tuberculosisin BCG vaccinated individuals exposed to a patient with tuberculosisVirulence, 2010
- Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent childrenJournal of Inflammation, 2010
- Sexual Inequality in TuberculosisPLOS Medicine, 2009
- Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in UgandaPLOS ONE, 2008
- Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in childrenThorax, 2006
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006